Abstract:
PURPOSE: Provided is a pharmaceutical composition for treating liver diseases containing the extract of natural products with Semisulcospira libertina (Gould) extract as active ingredient. The composition has excellent inhibition effect on hepatic fibrosis. CONSTITUTION: A pharmaceutical composition for treating liver diseases is characterized by containing Semisulcospira libertina (Gould) extract as active ingredient and it further contains the extract of natural products selected from Artemisia Messerschmidtiana Besser, Hovenia dulcis Thumb, garlic, Paeonia japonica var. pilosa, Angelica gigas Nakai, Polygonatum odoratum Druce var., licorice root, jujube, cinnamon, dried ginger and Gardenia jasminoides Ellis.
Abstract:
The present invention relates to a composition for alleviating arthritis, which is effective for alleviating rheumatic arthritis symptoms by comprising Cirsium japonicum var. ussuriense leap extracts, and more specifically, to a composition for alleviating arthritis, which is highly effective in alleviating arthritis by comprising Cirsium japonicum var. ussuriense leap extracts, significantly decreasing infiltration of not only inflammatory cell but also mast cell, inhibiting cytokine which induces inflammation such as PGE2, TNF-α, IL-6, and IL-4, and increasing IL-10 which is anti-inflammatory cytokine.
Abstract:
The present invention relates to a composition containing a thistle extract for preventing and alleviating ischemic stroke, and more specifically, to a composition for effectively alleviating symptoms of cerebral infraction by inhibiting generation of ischemic stroke such as cerebral infraction and transient ischemic attacks, alleviating the symptoms, and especially decreasing the size of cerebral infraction. The composition contains 0.5-20 wt% of the thistle extract based on the total weight of the composition.
Abstract:
PURPOSE: A composition containing a Cirsium japonicum extract for improving blood circulation is provided to suppress hemolysis of erythrocytes, to protect oxidative damage to plasma, and to prevent blood vessel injuries, thereby improving blood circulation and preventing and treating diseases. CONSTITUTION: A composition for improving blood circulation contains 1-1000 mg/kg of a Cirsium japonicum extract. The composition is used for preventing hemolysis and oxidative damage to plasma. The composition is also used for treating thrombosis. The composition is a health food.
Abstract:
A method of increasing isoflavone content by hydropriming and osmopriming treatment of soybeans consecutively is provided to increase the isoflavone content by 10 to 40% due to soybeans. The germinated soybeans with increased isoflavone content are used to manufacture high functional fermented soybeans. Soybeans are soaked in purified water at 20 to 25deg.C for 4 to 6hr, hydrated, soaked in inorganic salt solutions for 4 to 6hr and germinated at 20 to 25deg.C and 85% relative humidity for 24 to 48hr in an incubator to give germinated soybeans with increased isoflavone content. The inorganic salt is any one selected from NaCl, KNO3 or MgSO4. High functional fermented soybeans are obtained by steaming the germinated soybeans with increased isoflavone content at 121deg.C for 60min, cooling to 50deg.C, inoculating with 2% by volume of Bacillus subtilis cultures and fermenting at 40deg.C for 72hr.
Abstract:
PURPOSE: A hangover relieving agent containing a flavonoid and taurine is provided to ensure the synergic function of extracted flavonoid and taurine and to treat and prevent liver damage. CONSTITUTION: A hangover relieving agent contains a flavonoid and taurine extracted from Atractylodis Rhizoma alba, Puerariae Radix, Cyperi Rhizoma, Cinnamomi Cortex, Agastachis Herba, Alpinia officinarum, Hordei Fructus Germinatus, Caryophylli Flos, Aurantii nobilis Pericarpium, or Ginseng Radix rubra. The hangover relieving agent is used for treating or preventing a fatty liver, alcoholic liver disease, liver cirrhosis, or cholestasis.